UK startup Astral Systems has developed a first-of-its-kind 'Multi-State Fusion' (MSF) reactor that can be used to produce vital medical isotopes. These isotopes can be used for killing cancer cells in radiotherapy and as radioactive tracers in the body to help spot medical conditions through imaging. The new technology has the potential to revolutionise cancer diagnosis and treatment.